We found that anti-Wnt5a, but not a mAb of irrelevant specificity, could significantly inhibit anti-apoptotic effects of CLL cells when co-cultured with NLCs (Fig. 3A). The gene discussed is WNT5A; the disease is B-cell chronic lymphocytic leukemia.